167. マルファン症候群 Marfan syndrome Clinical trials / Disease details
臨床試験数 : 21 / 薬物数 : 40 - (DrugBank : 11) / 標的遺伝子数 : 10 - 標的パスウェイ数 : 50
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ChiCTR2100054172 | 2021-12-31 | 2021-12-10 | Investigation of the value of IMPATT method in the diagnosis of marfan syndrome | A single center, double-blind, diagnostic study on evaluating the value of IMPATT method in the diagnosis of marfan syndrome | Marfan Syndrome | Gold Standard:The 2010 revised Ghent II diagnostic criteria.;Index test:IMPATT alone, single department (cardiology/surgery, ophthalmology, orthopedics), MDT (cardiology/surgery + ophthalmology + orthopedics), IMPATT combined.; | The First Affiliated Hospital of Gannan Medical College | NULL | Pending | 0 | 80 | Both | Target condition:30;Difficult condition:165 | N/A | China |